BNP at discharge in acute heart failure patients: is it all about volemia? A study using impedance cardiography to assess fluid and hemodynamic status.

[1]  A. Coats,et al.  Ethical authorship and publishing. , 2009, International journal of cardiology.

[2]  D. Atar,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 ‡ , 2008, European journal of heart failure.

[3]  G. Fonarow,et al.  Albumin levels predict survival in patients with systolic heart failure. , 2008, American heart journal.

[4]  A. Jaffe,et al.  Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage. , 2008, Clinical chemistry.

[5]  R. McKelvie,et al.  Physiological, pathological, pharmacological, biochemical and hematological factors affecting BNP and NT-proBNP. , 2008, Clinical biochemistry.

[6]  A. Maisel,et al.  Natriuretic peptides. , 2007, Journal of the American College of Cardiology.

[7]  A. Cohen-Solal,et al.  Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. , 2007, Journal of the American College of Cardiology.

[8]  Horng H Chen,et al.  Heart failure: a state of brain natriuretic peptide deficiency or resistance or both! , 2007, Journal of the American College of Cardiology.

[9]  Y. Pinto,et al.  Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea. , 2007, Archives of internal medicine.

[10]  G. Filippatos,et al.  Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. , 2006, The American journal of medicine.

[11]  Serguei V. S. Pakhomov,et al.  Systolic and diastolic heart failure in the community. , 2006, JAMA.

[12]  Y. Kihara,et al.  B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. , 2006, Journal of the American College of Cardiology.

[13]  Antoni Bayes-Genis,et al.  NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. , 2006, European heart journal.

[14]  G. Fonarow,et al.  B-type natriuretic peptide levels in obese patients with advanced heart failure. , 2006, Journal of the American College of Cardiology.

[15]  M. O’Donoghue,et al.  The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. , 2005, Journal of cardiac failure.

[16]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[17]  G. Kaysen,et al.  POOR NUTRITIONAL STATUS AND INFLAMMATION: Serum Albumin: Relationship to Inflammation and Nutrition , 2004, Seminars in dialysis.

[18]  N. Albert,et al.  Equivalence of the bioimpedance and thermodilution methods in measuring cardiac output in hospitalized patients with advanced, decompensated chronic heart failure. , 2004, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[19]  A. Ferreira,et al.  N-Terminal–Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure Patients , 2004, Circulation.

[20]  C. Mueller,et al.  Hepatic proteins and nutrition assessment. , 2004, Journal of the American Dietetic Association.

[21]  D. Mancini,et al.  Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes. , 2004, The American journal of cardiology.

[22]  H. Müller,et al.  Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients. , 2004, Kidney international.

[23]  Gabriel Thabut,et al.  Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. , 2004, Journal of the American College of Cardiology.

[24]  G. Habib,et al.  Hypoalbuminemia in elderly patients with acute diastolic heart failure. , 2003, Journal of the American College of Cardiology.

[25]  Richard Kamin,et al.  Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. , 2003, Journal of the American College of Cardiology.

[26]  W. Hundley,et al.  Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. , 2002, JAMA.

[27]  Keith C. Norris,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  A. Ferreira,et al.  Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcome after hospital discharge in patients with heart failure. , 2002, The American journal of medicine.

[29]  M. Drazner,et al.  Comparison of impedance cardiography with invasive hemodynamic measurements in patients with heart failure secondary to ischemic or nonischemic cardiomyopathy. , 2002, The American journal of cardiology.

[30]  L. Morrison,et al.  B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. , 2002, Annals of emergency medicine.

[31]  L. Lenert,et al.  A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. , 2001, Journal of the American College of Cardiology.

[32]  G. Fonarow,et al.  Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. , 2000, American heart journal.

[33]  M R Shah,et al.  The congestion score: a simple tool for a complicated disease? , 2000, American heart journal.

[34]  David Roth,et al.  A simplified equation to predict glomerular filtration rate from serum creatinine , 2000 .

[35]  N. Arakawa,et al.  Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure. , 1998, American heart journal.

[36]  E. Antman,et al.  Cardiovascular biomarkers : pathophysiology and disease management , 2006 .